Results 261 to 270 of about 4,259,087 (330)
Some of the next articles are maybe not open access.
European Journal of Medicinal Chemistry, 2020
'Epigenetic' regulation of genes via post-translational modulation of proteins is the current mainstay approach for the disease therapies, particularly explored in the Histone Deacetylase (HDAC) class of enzymes.
G. N. Vaidya +8 more
semanticscholar +3 more sources
'Epigenetic' regulation of genes via post-translational modulation of proteins is the current mainstay approach for the disease therapies, particularly explored in the Histone Deacetylase (HDAC) class of enzymes.
G. N. Vaidya +8 more
semanticscholar +3 more sources
European Journal of Medicinal Chemistry, 2022
HDAC inhibitors and NO donors have both demonstrated independently broad therapeutic potential in a variety of diseases. Borretto et al. presented the topic of NO-HDAC dual inhibitors for the first time in 2013 as an attractive new topic. Here we collected the general structure of all synthesized NO-HDAC dual inhibitors, lead compounds, synthesis ...
Razieh Ghodsi, Negar Omidkhah
exaly +3 more sources
HDAC inhibitors and NO donors have both demonstrated independently broad therapeutic potential in a variety of diseases. Borretto et al. presented the topic of NO-HDAC dual inhibitors for the first time in 2013 as an attractive new topic. Here we collected the general structure of all synthesized NO-HDAC dual inhibitors, lead compounds, synthesis ...
Razieh Ghodsi, Negar Omidkhah
exaly +3 more sources
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
Life Science, 2021The role of genetic and epigenetic factors in tumor initiation and progression is well documented. Histone deacetylases (HDACs), histone methyl transferases (HMTs), and DNA methyl transferases.
M. Ramaiah +2 more
semanticscholar +1 more source
HDAC inhibitors: Promising agents for leukemia treatment.
Biochemical and Biophysical Research Communications - BBRC, 2023The essential role of epigenetic modification in the pathogenesis of a series of cancers have gradually been recognized. Histone deacetylase (HDACs), as well-known epigenetic modulators, are responsible for DNA repair, cell proliferation, differentiation,
Yun-Hua Deng, Qian Cheng, Jing He
semanticscholar +1 more source
Inside HDAC With HDAC Inhibitors
European Journal of Medicinal Chemistry, 2010Histone deacetylase inhibitors are a large group of diverse molecules intrinsically able to inhibit cell proliferation in various cancer cell lines. Their apoptotic effects have been linked to the modulation in the expression of several regulatory tumor suppressor genes caused by the modified status of histone acetylation, a key event in chromatin ...
Philippe Bertrand
exaly +3 more sources
Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics
Advances in Cancer Research, 2018James C Chou +2 more
exaly +2 more sources
Multi-targeted HDAC inhibitors as Anticancer Agents: Current Status and Future Prospective.
Current Medicinal Chemistry, 2022Multi-targeted agents can interact with multiple targets sequentially, resulting in synergistic and more effective therapies for several complicated disorders, including cancer, even with relatively modest activity.
H. Rajak +6 more
semanticscholar +1 more source
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.
Bioorganic & Medicinal Chemistry, 2021Histone deacetylases (HDACs) play a key role in the homeostasis of protein acetylation in histones and have recently emerged as a therapeutic target for numerous diseases.
X. Qiu +6 more
semanticscholar +1 more source
Immunology & Cell Biology, 2011
Combination antiretroviral therapy (cART) has led to a very substantial reduction in morbidity and mortality in HIV‐infected patients; however, cART alone is unable to cure HIV and therapy is lifelong. Therefore, a new strategy to cure HIV is urgently needed.
Wightman, F +3 more
openaire +3 more sources
Combination antiretroviral therapy (cART) has led to a very substantial reduction in morbidity and mortality in HIV‐infected patients; however, cART alone is unable to cure HIV and therapy is lifelong. Therefore, a new strategy to cure HIV is urgently needed.
Wightman, F +3 more
openaire +3 more sources

